Biotechnology company Blackrock Neurotech received a strategic investment of $200 million from Tether's venture capital firm

ChainCatcher news, according to The Block, biotechnology company Blackrock Neurotech announced a strategic investment of $200 million from Tether's venture capital arm, Tether Evo.

After this round of investment, Tether becomes the majority shareholder of Blackrock Neurotech. This investment will help Blackrock Neurotech fund the commercialization and promotion of its medical solutions and support its research and development efforts.